Cargando…
Mutation profile of acute myeloid leukaemia in a Chinese cohort by targeted next‐generation sequencing
BACKGROUND: Acute myeloid leukaemia (AML) results from the clonal expansion of blast cells of myeloid origin driven by genomic defects. The advances in next‐generation sequencing (NGS) have allowed the identification of many mutated genes important in the pathogenesis of AML. AIMS: In this study, we...
Autores principales: | Lit, Benny Man Wai, Guo, Belinda B., Malherbe, Jacques A. J., Kwong, Yok Lam, Erber, Wendy N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575498/ https://www.ncbi.nlm.nih.gov/pubmed/34617422 http://dx.doi.org/10.1002/cnr2.1573 |
Ejemplares similares
-
Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine
por: Hwang, Yu-Yan, et al.
Publicado: (2012) -
Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next-generation sequencing
por: Li, Ying, et al.
Publicado: (2019) -
Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
por: Tse, Eric, et al.
Publicado: (2011) -
Oral arsenic trioxide for treating acute promyelocytic leukaemia: Implications for its worldwide epidemiology and beyond
por: Kumana, Cyrus R., et al.
Publicado: (2022) -
The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases
por: Chin, Lynn, et al.
Publicado: (2022)